AB106. P080. Interferon gamma-inducible protein 10 in pancreatic cancer progression (original) (raw)
IP-10/CXCL10 induction in human pancreatic cancer stroma influences lymphocytes recruitment and correlates with poor survival
Michael Silva, Maria MANUELA Gaspar, Ruth Muschel
Oncotarget, 2014
View PDFchevron_right
CXCL10/CXCR3 signaling contributes to an inflammatory microenvironment and its blockade enhances progression of murine pancreatic precancerous lesions
Veethika Pandey
eLife
View PDFchevron_right
Expression of Interferon-Gamma- Inducible Protein10 and Its Receptor CXCR3 in Chronic Pancreatitis
Jay Dev
Pancreatology, 2007
View PDFchevron_right
CXCL12 Chemokine Expression Suppresses Human Pancreatic Cancer Growth and Metastasis
Noah Zimmerman
PLoS ONE, 2014
View PDFchevron_right
IP-10/CXCL10 attracts regulatory T cells: implication for pancreatic cancer
Thomas Brunner
OncoImmunology, 2015
View PDFchevron_right
CXCR3 and Cognate Ligands are Associated with Immune Cell Alteration and Aggressiveness of Pancreatic Ductal Adenocarcinoma
Pranita Atri
Clinical Cancer Research, 2020
View PDFchevron_right
Expression and potential function of the CXC chemokine CXCL16 in pancreatic ductal adenocarcinoma
Moritz Wente
International journal of …, 2008
View PDFchevron_right
Dual roles for CXCL4 chemokines and CXCR3 in angiogenesis and invasion of pancreatic cancer
Shih-che Sue
Cancer research, 2016
View PDFchevron_right
Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells
Andrew Lowy
Journal of Translational Medicine, 2012
View PDFchevron_right
Multi-omic Characterization of Pancreatic Ductal Adenocarcinoma Relates CXCR4 mRNA Expression Levels to Potential Clinical Targets
Andreas Seeber
Clinical Cancer Research
View PDFchevron_right
CXCL12 in Pancreatic Cancer: Its Function and Potential as a Therapeutic Drug Target
Rolf Brekken
Cancers
View PDFchevron_right
CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response
Maria Pawula
2020
View PDFchevron_right
CC Chemokine Receptor 9 Enhances Proliferation in Pancreatic Intraepithelial Neoplasia and Pancreatic Cancer Cells
Andrew Lowy
Journal of Gastrointestinal Surgery, 2009
View PDFchevron_right
Chemokines beyond chemo-attraction: CXCL10 and its significant role in cancer and autoimmunity
Nathan Karin
Cytokine, 2018
View PDFchevron_right
The emerging role of CXCL10 in cancer (Review)
Jonathan Stiles
Oncology Letters, 2011
View PDFchevron_right
CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma
Nigel Jamieson
Cancer cell, 2016
View PDFchevron_right
Role of IP-10/CXCL10 in the progression of pancreatitis-like injury in mice after murine retroviral infection
Hiroyuki Yoneyama
American Journal of Physiology-Gastrointestinal and Liver Physiology, 2006
View PDFchevron_right
The Chemokine Receptor CX3CR1 Is Involved in the Neural Tropism and Malignant Behavior of Pancreatic Ductal Adenocarcinoma
Luca Cervo
Cancer Research, 2008
View PDFchevron_right
Identification of chemokine CXCL10 in tumor microenvironment by antibody array as a prognostic marker in hepatocellular carcinoma
Xin-yuan Guan
Neoplasma, 2017
View PDFchevron_right
S2008 CXC-Chemokine/CXCR2 Biological Axis Promotes Angiogenesis In Vitro and In Vivo in Pancreatic Cancer
Sushovan Guha
Gastroenterology, 2009
View PDFchevron_right
Pleiotropic effects of CXC chemokines in gastric carcinoma: differences in CXCL8 and CXCL1 expression between diffuse and intestinal types of gastric carcinoma
Stephanie Brandlein
Clinical and Experimental Immunology, 2003
View PDFchevron_right
The importance of CXCR4 expression in tumor stroma as a potential biomarker in pancreatic cancer
Raquel Bodoque Villar
View PDFchevron_right
CXCL8/IL-8 and CXCL12/SDF-1α co-operatively promote invasiveness and angiogenesis in pancreatic cancer
Sushovan Guha
International Journal of Cancer, 2009
View PDFchevron_right
Inhibition of CXCLs/CXCR2 axis in the tumor microenvironment might be a potent therapeutics for pancreatic cancer
Hideaki Ijichi
Oncoimmunology, 2012
View PDFchevron_right
Cancer cell chemokines direct chemotaxis of activated stellate cells in pancreatic ductal adenocarcinoma
Edna Cukierman
Laboratory investigation; a journal of technical methods and pathology, 2017
View PDFchevron_right
Inflammatory Mechanisms Contributing to Pancreatic Cancer Development
ANDY CHEN
Annals of Surgery, 2004
View PDFchevron_right
The CC Chemokine MCP-1/CCL2 in Pancreatic Cancer Progression: Regulation of Expression and Potential Mechanisms of Antimalignant Activity1
Cosimo Sperti
Cancer Research, 2003
View PDFchevron_right
Synergistic Expression of the CXCL10 Gene in Response to IL-1 and IFN- Involves NF- B, Phosphorylation of STAT1 at Tyr701, and Acetylation of Histones H3 and H4
Michael Karlstad
The Journal of Immunology, 2013
View PDFchevron_right
Differential role of CXCR3 in inflammation and colorectal cancer
Manoj Mishra
Oncotarget, 2018
View PDFchevron_right
CXCR4-A Prognostic and Clinicopathological Biomarker for Pancreatic Ductal Adenocarcinoma: A Meta-Analysis
Leila Telan
PLOS ONE, 2015
View PDFchevron_right
Canonical and alternative transcript expression of PAX6 and CXCR4 in pancreatic cancer
Paul Grippo
Oncology Letters
View PDFchevron_right
The Chemokine CXCL16 and Its Receptor, CXCR6, as Markers and Promoters of Inflammation-Associated Cancers
Merav Darash-yahana
PLoS ONE, 2009
View PDFchevron_right
Differential expression of chemokines in normal pancreas and in chronic pancreatitis
Christoph Mueller
Gastroenterology, 2000
View PDFchevron_right